The impact of including a medication review in an integrated care pathway: A pilot study
- PMID: 36164674
- DOI: 10.1111/bcp.15543
The impact of including a medication review in an integrated care pathway: A pilot study
Abstract
Aim: The objective of the present study was to measure the impact of the intervention of combining a medication review with an integrated care approach on potentially inappropriate medications (PIMs) and hospital readmissions in frail older adults.
Methods: A cohort of hospitalized older adults enrolled in the French PAERPA integrated care pathway (the exposed cohort) was matched retrospectively with hospitalized older adults not enrolled in the pathway (unexposed cohort) between January 1st, 2015, and December 31st, 2018. The study was an analysis of French health administrative database. The inclusion criteria for exposed patients were admission to an acute care department in a general hospital, age 75 years or over, at least three comorbidities or the prescription of diuretics or oral anticoagulants, discharge alive and performance of a medication review.
Results: For the study population (n = 582), the mean ± standard deviation age was 82.9 ± 4.9 years, and 380 (65.3%) were women. Depending on the definition used, the overall median number of PIMs ranged from 2 [0;3] on admission to 3 [0;3] at discharge. The intervention was not associated with a significant difference in the mean number of PIMs. Patients in the exposed cohort were half as likely to be readmitted to hospital within 30 days of discharge relative to patients in the unexposed cohort.
Conclusion: Our results show that a medication review was not associated with a decrease in the mean number of PIMs. However, an integrated care intervention including the medication review was associated with a reduction in the number of hospital readmissions at 30 days.
Keywords: hospital readmission; integrated care; older adults; potentially inappropriate medications.
© 2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
References
REFERENCES
-
- Thomas RE, Nguyen LT, Jackson D, Naugler C. Potentially inappropriate prescribing and potential prescribing omissions in 82,935 older hospitalised adults: association with hospital readmission and mortality within six months. Geriatrics (Basel). 2020;5(2):37. doi:10.3390/geriatrics5020037
-
- Scott IA, Pillans PI, Barras M, Morris C. Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Therapeut Adv Drug Saf. 2018;9(9):559-573. doi:10.1177/2042098618784809
-
- Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175-1188. doi:10.1007/s00228-011-1061-0
-
- Simões PA, Santiago LM, Maurício K, Simões JA. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: a nationwide cross-sectional study. PPA. 2019;13:1569-1576. doi:10.2147/PPA.S219346
-
- Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Petzold M, Hägg S. Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol. 2015;71(12):1525-1533. doi:10.1007/s00228-015-1950-8
MeSH terms
LinkOut - more resources
Full Text Sources